Clinically, low AKR7A3 expression is associated with poor overall survival, elevated serum AFP and poor differentiation of HCC tissue, indicating the important role of AKR7A3 in the suppression of HCC. The gene discussed is AKR7A3; the disease is hepatocellular carcinoma.